Reports

Ideas That Generate Results

EPO Biosimilars - The Future of Erythropoietin Market

EPO Biosimilars - The Future of Erythropoietin Market

Format :  Adobe Reader (PDF) Upto 24 hour delivery
Publish Date : Aug, 2016| No. of Pages : 45

Share |
 
Please make your selection :
Electronic Access - Single User License
US$ 600.00
CD-ROM Mail Delivery
US$ 700.00
Hard Copy Mail Delivery
US$ 700.00
Electronic Access - Multi-User License
US$ 1000.00
Erythropoietin is a hormone produced by healthy kidneys. This hormone prompts the bone marrow to make the red blood cells, which then carry oxygen throughout the body. Erythropoietin is used to treat anemia resulting from kidney failure or cancer treatment. It is considered to be an alternative to blood transfusions. Over the last few years, the global erythropoietin industry has been showing a sluggish growth due to patent expiry of biologic drugs. However, the biosimilar versions of these drugs are expected to witness precipitous growth owing to their low cost. 
 
As per RNCOS report “EPO Biosimilars - The Future of Erythropoietin Market”, the global erythropoietin market is anticipated to reach an approximate value of US$ 7 Billion by 2020. This report provides a detailed analysis of the current and future market scenario of the global erythropoietin market. The report highlights biosimilar erythropoietin at various stages of clinical development. In addition, the report provides insight about the major drivers and challenges, along with the latest trends and developments impacting the industry growth.
 
The global erythropoietin market has been segmented into biologic and biosimilar erythropoietin markets. The report also highlights the various biologic and biosimilar erythropoietin drugs currently available in the market. Furthermore, the global erythropoietin market has also been segmented on the basis of their applications.  Based on geography, the report divides the market into the US, Europe, and Asia-Pacific.
 
The last section of the report discusses about the prominent players in global erythropoietin market. Market share analysis of these players is also provided in the report. A brief business overview and financial information about each of these players has been provided along with their product portfolios. The recent development of every player has also been presented in the report. Overall, the research contains exhaustive information that will help clients in formulating market strategies and assessing opportunity areas in the global erythropoietin market.
Not able to find data you are looking for? Ask our Research Analyst.

media citation

get in touch

Please fill-in the information below.